<DOC>
	<DOCNO>NCT02796534</DOCNO>
	<brief_summary>Patients type 1 diabetes poor glycemic control could lead macrovascular neuropathic complication ; addition optimal treatment , prevention diabetes complication require control associate risk factor , hypertension dyslipidemia . Sleep apnea syndrome public health problem due high prevalence mark morbidity mortality , one increasingly interesting aspect relationship metabolic disorder , specifically diabetes.Obstructive sleep apnea syndrome seem underestimated population . In context , appear important estimate prevalence sleep respiratory diseases patient type 1 diabetes .</brief_summary>
	<brief_title>Prevalence Obstructive Sleep Apnea Syndrome Type 1 Diabetic Patients Treated With Insulin Pump ( At1Home )</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Male female age 18 75 year Type 1 diabetic Treated insulin therapy external pump Take home monitoring part usual care insulin therapy external pump Voluntary participate research write informed consent Patient affiliate social security similar regime Privited person liberty judicial administrative decision , person cover legal protection ( pregnant lactate woman , patient guardianship ) Article L11218 In exclusion period study Patient may , discretion investigator , comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Obstructive Sleep Apnea Syndrome</keyword>
</DOC>